stock offering
Lucid Diagnostics Raises $16.1M in Public Offering
The firm raised the money last week in a public offering of 14,375,000 common shares, and it will use the money for working capital and general corporate purposes.
Lucid Diagnostics to Raise $15.3M in Registered Direct Offering
The firm intends to use the net proceeds from the offering for working capital and other general corporate purposes.
Sera Prognostics Prices $50M Stock Offering
The firm plans to use the proceeds to support commercial expansion in the US and EU, and for research, potential regulatory submissions, and general corporate purposes.
VolitionRx to Raise up to $21.5M in Registered Direct Offering
The firm expects to bring in $7 million upfront and up to another $14.5 million through milestone-linked warrants.
Bluejay Diagnostics Prices $8.75M Public Offering
The firm said that it plans to use the money to repay outstanding debt, to support clinical studies and other R&D, and for general working capital.